DISCOUNT ZERTIFIKAT - ABBVIE Share Price

Certificat

DE000ME67XG0

Real-time Bid/Ask 15:22:43 02/07/2024 BST
128.64 EUR / 128.72 EUR -0.03% Intraday chart for DISCOUNT ZERTIFIKAT - ABBVIE
Current month-0.14%
1 month+2.19%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
02/07/24 128.6 -0.09%
01/07/24 128.7 -0.14%
28/06/24 128.9 -0.01%
27/06/24 128.9 -0.28%
26/06/24 129.3 +0.22%

Delayed Quote Börse Stuttgart

Last update July 02, 2024 at 02:11 pm

More quotes

Static data

Product typeCertificats Discount
Buy / SellCALL
Underlying ABBVIE INC.
Issuer Morgan Stanley
WKN ME67XG
ISINDE000ME67XG0
Date issued 02/01/2024
Cap 140 $
Last trading day 20/09/2024
Maturity 20/09/2024 (80 Days)
Parity 1 : 1
Emission price 119.8
Emission volume N/A
Payment day 27/09/2024
Bonus-
Settlement règlement en espèces
Currency EUR

Technical Indicators

Discount (ask) 17.48 %
Sideways yield 1.386 %
Sideways yield pa 6.322 %
Outperformance point 169.7 $
Break even 138.09 €
Highest since issue 129.3
Lowest since issue 117.8
Spread 0.03
Spread %0.02%
Distance Cap 27.52 $
Distance Cap %+16.43%
Max. earning 1.783
Max. earning % 1.386 %

Company Profile

AbbVie Inc. specializes in therapeutic drug research and development. Its products are intended for treating rheumatoid arthritis, psoriasis, Crohn's disease, thyroid disease, Parkinson's disease, HIV, complications of mucoviscidosis, low testosterone levels, and complications associated with chronic renal disease. Net sales are distributed geographically as follows: the United States (77.1%), Germany (2.3%), Canada (2%), Japan (1.9%), China (1.7%), France (1.4%), Spain ( 0.9%), Italy (0.9%), Australia (0.9%), Brazil (0.8%), United Kingdom (0.8%) and others (9.3%).
Sector
-
More about the company

Ratings for AbbVie Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: AbbVie Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
170.4 USD
Average target price
183.2 USD
Spread / Average Target
+7.55%
Consensus